s6y
Company name or ticker
Search
CASI Pharmaceuticals, Inc.
3
Qian Kun: Initial statement of beneficial ownership of securities
Filed
Monday, April 13, 2026
Period
Mar 18, 2026
Accession number
0001104659-26-042658
Documents
OWNERSHIP DOCUMENT
3
On sec.gov
Filing index
All files
Complete submission text
SGML header